Antidiabetic Agents

Multum Therapeutic Class Comparison, United States, 2024

Total Prescriptions in (2024)

Drug Name	Total Prescriptions (2024)	Percent Share
Metformin	82,288,617	31.7%
Semaglutide	40,938,166	15.8%
Insulin Glargine	21,364,478	8.2%
Empagliflozin	20,797,026	8%
Tirzepatide	18,694,231	7.2%
Glipizide	12,809,578	4.9%
Insulin Lispro	10,412,617	4%
Dulaglutide	9,211,040	3.5%
Insulin Aspart	8,979,716	3.5%
Dapagliflozin	8,017,363	3.1%
Insulin Degludec	5,466,073	2.1%
Sitagliptin	5,147,491	2%
Glimepiride	5,109,702	2%
Pioglitazone	4,851,830	1.9%
Insulin Human; Insulin Isophane Human	2,227,310	0.9%
Insulin Isophane	1,314,871	0.5%
Insulin Detemir	1,310,971	0.5%
Liraglutide	826,310	0.3%

Total Prescriptions by Drug Over Time

Drug Class Prescribing Trends Over Time

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2014-2024. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 2026.08. Read more about the ClinCalc DrugStats database.

All ClinCalc DrugStats figures and graphs on this page are licensed under Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0).

Search

Mailing List

Get Email Updates

New and Popular

Open Menu

Cite This Page

Show AMA citation

PharmPraxis - Not more noise. Better NAPLEX questions.

Disclaimer - Privacy Policy - Contact Us
Updated Sep 12, 2021

Top